Selective pharmacological inhibition of distinct nitric oxide synthase isoforms.
about
Nitric oxide synthase in cardiac sarcoplasmic reticulumNeuronal nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivoShaping of monocyte and macrophage function by adenosine receptorsInhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injuryHost modulation therapy: An indispensable part of perioceuticsImplications for isoform-selective inhibitor design derived from the binding mode of bulky isothioureas to the heme domain of endothelial nitric-oxide synthaseStructural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthaseStructure-based design, synthesis, and biological evaluation of lipophilic-tailed monocationic inhibitors of neuronal nitric oxide synthasePeripheral but crucial: A hydrophobic pocket (Tyr706, Leu337, and Met336) for potent and selective inhibition of neuronal nitric oxide synthasePotent, Highly Selective, and Orally Bioavailable Gem -Difluorinated Monocationic Inhibitors of Neuronal Nitric Oxide SynthaseIntramolecular hydrogen bonding: A potential strategy for more bioavailable inhibitors of neuronal nitric oxide synthaseIn search of potent and selective inhibitors of neuronal nitric oxide synthase with more simple structuresChiral linkers to improve selectivity of double-headed neuronal nitric oxide synthase inhibitorsAccessible Chiral Linker to Enhance Potency and Selectivity of Neuronal Nitric Oxide Synthase InhibitorsThe nitric oxide hypothesis of late preconditioningNa+ - and Cl- -coupled active transport of nitric oxide synthase inhibitors via amino acid transport system B(0,+)Role of inducible nitric oxide synthase in regulation of pulmonary vascular tone in the late gestation ovine fetusInteractions between apelin and angiotensin II on rat portal veinTwenty-five years since the discovery of endothelium-derived relaxing factor (EDRF): does a dysfunctional endothelium contribute to the development of type 2 diabetes?The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene.The use of diagnostic frequency continuous ultrasound to improve microcirculatory function after ischemia-reperfusion injury.Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic miceNitrergic response to cyclophosphamide treatment in blood and bone marrowRoles of nitric oxide synthase isoforms in cutaneous vasodilation induced by local warming of the skin and whole body heat stress in humans.Peroxynitrite in airway diseases.Review article: the potential role of nitric oxide in chronic inflammatory bowel disorders.A spontaneous animal model of intestinal dysmotility evoked by inflammatory nitrergic dysfunction.Potent and selective neuronal nitric oxide synthase inhibitors with improved cellular permeability.Antioxidant actions of plant foods: use of oxidative DNA damage as a tool for studying antioxidant efficacy.Comparison of methods for proanthocyanidin extraction from pine (Pinus densiflora) needles and biological activities of the extracts.Neuroprotection in acute ischaemic stroke. II: Clinical potential.Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophilsInhibitory effects of palmultang on inflammatory mediator production related to suppression of NF-κB and MAPK pathways and induction of HO-1 expression in macrophagesInducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and miceNaïve human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivoHyperbaric oxygen inhibits ischemia-reperfusion-induced neutrophil CD18 polarization by a nitric oxide mechanism.Fermentation by Lactobacillus enhances anti-inflammatory effect of Oyaksungisan on LPS-stimulated RAW 264.7 mouse macrophage cells.Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis.Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks.Oral administration of cytosolic PLA2 inhibitor arachidonyl trifluoromethyl ketone ameliorates cauda equina compression injury in rats
P2860
Q22008689-97356FE9-8319-4AA2-8BF7-6BF1051209B9Q24301869-0B788240-924E-4C09-AAE3-7540D22DBAD3Q24655330-862A8395-7073-42CA-9999-B28713DBC15EQ24813764-9ED40C25-9597-43DA-A139-F12C9F2F1F71Q26852306-FCA98EEB-03C9-404E-9182-3795CD256113Q27631560-A3662699-AE5F-40B1-B1DC-B66DB152F7E0Q27642934-065CB6AF-A43D-4F92-933D-268F2F36D578Q27663700-2B951AAA-EA2B-4649-8348-D5AFE5E84EBEQ27664423-FED5BCF7-F88D-4F68-A52D-AC130D582569Q27664466-173842D3-66CD-43B2-A51B-8A2342C8FD78Q27677512-7FCCB131-3D97-4F0D-82AF-E98149C3FBFDQ27679131-634D864E-EBA2-44B6-B86A-150BEBFAE01AQ27679840-B6E95DC7-CC0A-4C40-A053-E39572B4E41AQ27682403-0F362118-8069-467D-8883-6DE783A45AD4Q28290101-F91F2DFD-0C65-4B9B-95EE-700ED50DE54CQ28362810-CB4B8D09-E31A-4A2D-BFCA-FE08A5EDBA71Q28379295-A2589701-3179-4BC3-B700-734972EE866DQ28573763-198A6792-F2E7-4DC0-A8A6-D7E027F3089AQ30352122-F6AA7BED-50A5-43D9-9A83-ABA469AA8C8CQ30454405-2C76A0B9-CAB6-469C-96B4-7EB1C4CB48FCQ30492241-487516B7-2F69-48AC-94A8-103738757A55Q31146191-8DB302A9-8514-492A-8269-CC833D34F8FAQ33381750-07FB41D8-7293-4B0C-813F-471B922987BAQ33501901-D964A8D8-921F-4C97-9136-C8D0091FF662Q33534444-8E856A07-7EA8-4A54-B6A3-5CCA87FB61D2Q33548209-C9FA83C6-911E-473D-A1E0-456CCAF96F69Q33599727-0F5BEE41-1795-4CED-BEED-437DCC1C05D3Q33638377-16780C29-A5A0-4BCF-A445-F3F3B5D51E34Q33684321-E116FC99-4804-4958-9730-6A5D2A051817Q33695911-FEE43809-8F2C-480D-819E-DFFBF48EC6ABQ33747433-A9C372F6-3ADF-4BA3-97B1-8397CADD2D9BQ33747734-26513B92-90F6-4186-89FF-76EE2405EB5DQ33755794-CF7BC59F-463D-47F9-9BDA-52639B3B7FD2Q33857899-927FFF52-359E-47FD-8703-A7367E4C3EC1Q34038421-58EB336C-4AEB-487F-A6A0-537E486723A5Q34049064-B6B40E5C-844F-4C62-9819-73CDC61C4CDDQ34190365-E02533A5-285B-4A79-B74A-23060F529A8AQ34344162-93781CE3-8866-4A2A-B306-1E294BEDDD44Q34469372-7527671A-0DE7-49B5-B321-1083B5C2028CQ34476283-7625FDAF-D04D-49CA-A4CA-562FEADBDF4C
P2860
Selective pharmacological inhibition of distinct nitric oxide synthase isoforms.
description
1996 nî lūn-bûn
@nan
1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Selective pharmacological inhibition of distinct nitric oxide synthase isoforms.
@ast
Selective pharmacological inhibition of distinct nitric oxide synthase isoforms.
@en
Selective pharmacological inhibition of distinct nitric oxide synthase isoforms.
@nl
type
label
Selective pharmacological inhibition of distinct nitric oxide synthase isoforms.
@ast
Selective pharmacological inhibition of distinct nitric oxide synthase isoforms.
@en
Selective pharmacological inhibition of distinct nitric oxide synthase isoforms.
@nl
prefLabel
Selective pharmacological inhibition of distinct nitric oxide synthase isoforms.
@ast
Selective pharmacological inhibition of distinct nitric oxide synthase isoforms.
@en
Selective pharmacological inhibition of distinct nitric oxide synthase isoforms.
@nl
P1476
Selective pharmacological inhibition of distinct nitric oxide synthase isoforms.
@en
P2093
P304
P356
10.1016/0006-2952(95)02099-3
P407
P577
1996-02-01T00:00:00Z